title: Cdc20 turnover rate: a key determinant in cancer patient response to anti-mitotic therapies?
authors.affiliation: Department of Biochemistry, University of Leicester, Leicester, UK. amf5@le.ac.uk
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Fry
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D064199:Cdc20 Proteins / Q000235:genetics / Q000378:metabolism*; D059447:Cell Cycle Checkpoints; D006801:Humans; D008938:Mitosis / Q000187:drug effects* / Q000235:genetics; D009369:Neoplasms / Q000188:drug therapy* / Q000235:genetics
chemical_list: D064199:Cdc20 Proteins; C577488:CDC20 protein, human